Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · OTC
Our AI ranks Logicmark, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Its market capitalization is not available, so no size classification is given.
A per-ticker accuracy statistic for LGMK is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, LGMK included.
Follow LGMK free90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Orthopedic, Prosthetic & Surgical Appliances & Supplies peers listed below that report each metric.
| Metric | LGMK | Rank |
|---|---|---|
| EPS | $-16.55 | – |
| Metric | LGMK | Rank |
|---|---|---|
| ROE | -47.2% | 11/20 |
| ROA | -36.6% | 13/20 |
| ROIC | -42.6% | 15/21 |
| Gross Margin | 69.1% | 5/20 |
| Operating Margin | -51.8% | 14/21 |
| Net Margin | -49.6% | 15/18 |
| EBT Margin | -49.5% | 14/21 |
| Metric | LGMK | Rank |
|---|---|---|
| Current Ratio | 4.88x | 5/24 |
| Quick Ratio | 4.20x | 3/21 |
| D/E Ratio | 0.15x | 20/23 |
| Financial Leverage | 1.29x | 17/23 |
| Interest Coverage | -3.4x | 11/21 |
| Working Capital | $7M | 17/22 |
| Metric | LGMK | Rank |
|---|---|---|
| Operating Cash Flow | -$4M | 16/22 |
| Free Cash Flow | -$4M | 11/16 |
| Capital Spending | -$130K | 4/16 |
| FCF/Sales | -32.6% | 14/16 |
| CapEx/Sales | 1.0% | 10/16 |
| Metric | LGMK | Rank |
|---|---|---|
| Asset Turnover | 0.74x | 9/18 |
| Receivables Turnover | 1348.4x | 1/16 |
| Inventory Turnover | 3.2x | 7/21 |
| Fixed Assets Turnover | 82.2x | 3/18 |
| Days Sales Outstanding | 0 days | 16/16 |
| Days Inventory | 112 days | 15/21 |
| Payables Period | 44 days | 13/18 |
| Cash Conversion Cycle | 69 days | 11/15 |
| Metric | LGMK | Rank |
|---|---|---|
| Total Revenue | $12M | 14/18 |
| Operating Income | -$6M | 11/22 |
| Net Income | -$6M | 10/18 |
| R&D Expense | $540K | 17/19 |
| SG&A Expense | $20M | 14/19 |
| Cost of Goods Sold | $4M | 14/20 |
| Metric | LGMK | Rank |
|---|---|---|
| EPS Growth | -1477.7% | – |
| Total Current Assets | $9M | 50.9% of assets |
| Cash & Short-term Investments | $4M | 20.6% of assets |
| Accounts Receivable | $10K | 0.1% of assets |
| Inventory | $1M | 7.0% of assets |
| Total Liabilities | $2M | 11.9% of assets |
| Short-term Debt | $1M | 7.7% of assets |
Companies classified under the same SEC industry code as Logicmark, Inc. (Orthopedic, Prosthetic & Surgical Appliances & Supplies): 27 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| LGMK Logicmark, Inc. | ▼ | N/A |
| ISRG Intuitive Surgical Inc | ▼ | $149.10B |
| SNN Smith & Nephew Plc | ▼ | $24.45B |
| STE Steris Plc | ▼ | $21.23B |
| ZBH Zimmer Biomet Holdings, Inc. | ▼ | $17.56B |
| ALGN Align Technology Inc | ▼ | $10.20B |
| MSA Msa Safety Inc | ▼ | $7.01B |
| ESTA Establishment Labs Holdings Inc. | ▲ | $1.74B |
| CDRE Cadre Holdings, Inc. | ▶ | $1.12B |
| ENOV Enovis Corp | ▶ | $1.10B |
| AVR Anteris Technologies Global Corp. | ▼ | $629M |
| SMTI Sanara Medtech Inc. | ▼ | $323M |
| INGN Inogen Inc | ▶ | $168M |
| LAKE Lakeland Industries Inc | ▲ | $97M |
| NTRB Nutriband Inc. | ▲ | $71M |
| APT Alpha Pro Tech Ltd | ▲ | $59M |
| MYO Myomo, Inc. | ▲ | $51M |
| COCH Envoy Medical, Inc. | ▶ | $50M |
| MLSS Milestone Scientific Inc. | ▲ | $31M |
| LFWD Lifeward Ltd. | ▲ | $18M |
| UEEC United Health Products, Inc. | ▶ | $12M |
| RGNT Regentis Biomaterials Ltd. | ▼ | $8M |
| CLGN Collplant Biotechnologies Ltd | ▶ | $5M |
| RBOT Vicarious Surgical Inc. | ▼ | $360K |
| FEED Envue Medical, Inc. | ▼ | $320K |
| BBLG Bone Biologics Corp | ▲ | N/A |
| CUPR Cuprina Holdings (Cayman) Ltd | ▼ | N/A |
LogicMark delivered 8% year-over-year revenue growth to $2.9 million in Q3 2025, with gross margin steady at 66%. Management emphasized ongoing transformation toward a subscription-based, AI-enabled ...
Good afternoon, and welcome to LogicMark's Fourth Quarter and Full Year 2025 Conference Call. The speakers today are Chia-Lin Simmons, Chief Executive Officer; and Mark Archer, Chief Financial Officer ...
By M. Marin READ THE FULL REPORT LogicMark’s merger agreement to be acquired was approved at a special meeting of ...
Our AI ranks Logicmark, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
A per-ticker accuracy statistic for LGMK is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Logicmark, Inc. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
27 issuers in our coverage, LGMK included, share the SEC industry code Orthopedic, Prosthetic & Surgical Appliances & Supplies. The largest are: Intuitive Surgical Inc (ISRG), Smith & Nephew Plc (SNN), Steris Plc (STE), Zimmer Biomet Holdings, Inc. (ZBH), Align Technology Inc (ALGN), Msa Safety Inc (MSA).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.
Signals, companies, plans: answered from live data.
I read Intratio's daily model signals, company data and your account to answer in seconds, in your language.